1.23
price up icon0.82%   0.01
after-market Handel nachbörslich: 1.27 0.04 +3.25%
loading

Finanzdaten der Soligenix Inc-Aktie (SNGX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
6.64%
2.5805
2.7639 3.0265 3.7125 1.8652
Operating Income/Loss
6.64%
-2.5805
-2.7639 -3.0265 -3.7125 -1.8652
Nonoperating Income/Loss
19.98%
0.0495
0.0619 0.0752 0.316 0.1459
Income/Loss From Continuing Operations Before Tax
6.33%
-2.5309
-2.702 -3.2368 -3.3965 -1.7194
Income/Loss From Continuing Operations After Tax
6.33%
-2.5309
-2.702 -2.9513 -2.9874 -1.7194
Net Income/Loss
6.33%
-2.5309
-2.702 -3.2368 -2.9874 -1.7194
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
32.05%
4.3296
3.2787 3.0496 0.2838 2.2039
Diluted Average Shares
32.05%
4.3296
3.2787 3.0496 0.2838 2.2039
Basic Earnings Per Share
29.27%
-0.58
-0.82 -0.97 -1.14 -0.78
Diluted Earnings Per Share
29.27%
-0.58
-0.82 -0.97 -1.14 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):